These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694 [TBL] [Abstract][Full Text] [Related]
3. Pelvic exenteration for gynecological malignancies: an analysis of 15 cases operated on at a single institution. Mäenpää JU; Kangasniemi K; Luukkaala T Acta Obstet Gynecol Scand; 2010; 89(2):279-83. PubMed ID: 19916881 [TBL] [Abstract][Full Text] [Related]
4. Indications for primary and secondary exenterations in patients with cervical cancer. Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276 [TBL] [Abstract][Full Text] [Related]
5. [Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases]. Zhang Z; Zang R; Chen J Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):288-90. PubMed ID: 11775910 [TBL] [Abstract][Full Text] [Related]
6. Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis. Kraybill WG; Lopez MJ; Bricker EM Surg Gynecol Obstet; 1988 Mar; 166(3):259-63. PubMed ID: 3344455 [TBL] [Abstract][Full Text] [Related]
7. Pelvic exenteration for primary and recurrent gynaecological malignancies. de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559 [TBL] [Abstract][Full Text] [Related]
8. The role of surgery in the management of recurrent gynecologic cancer. Hogan WM; Boente MP Semin Oncol; 1993 Oct; 20(5):462-72. PubMed ID: 7692604 [No Abstract] [Full Text] [Related]
9. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients. Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266 [TBL] [Abstract][Full Text] [Related]
10. The assessment and surgical management of recurrent pelvic cancer of the female genitalia. Monaghan JM Br J Urol; 1997 Jul; 80 Suppl 1():62-5. PubMed ID: 9240227 [No Abstract] [Full Text] [Related]
12. Pelvic exenteration. Has it a role in 1987? A six year experience. Shepherd JH Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684 [TBL] [Abstract][Full Text] [Related]
19. The role of pelvic exenteration for sarcomatous malignancies. Reid GC; Morley GW; Schmidt RW; Hopkins MP Obstet Gynecol; 1989 Jul; 74(1):80-4. PubMed ID: 2733946 [TBL] [Abstract][Full Text] [Related]
20. Total pelvic exenteration: results from a multispecialty team approach to complex cancer surgery. Ho YH; Cheng C; Tay SK Int Surg; 2001; 86(2):107-11. PubMed ID: 11918234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]